Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00073710 · ClinicalTrials.gov registry record · Phase 4
Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
A Phase 4 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00073710: Completed Phase 4 study, sponsored by Abbott.
NCT00073710 is a Phase 4 study that has completed, run by Abbott. The registered enrollment target is 30 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00073710, a Phase 4 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
A study to investigate the effects of Zemplar and Calcijex on intestinal calcium absorption in hemodialysis subjects.
Interventions
- DRUG Zemplar
- PROCEDURE 42 Ca carbonate absorption via single tracer method
- DRUG Calcijex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2004-09 |
| Phase | Phase 4 |
What the finished NCT00073710 record still lists
NCT00073710 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Zemplar is the first listed.
NCT00073710 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00073710 about?
NCT00073710 is a clinical study titled "Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium". A study to investigate the effects of Zemplar and Calcijex on intestinal calcium absorption in hemodialysis subjects.
What is the current status of trial NCT00073710?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2004-09.
What interventions are being tested in trial NCT00073710?
The interventions under investigation include: Zemplar (DRUG), 42 Ca carbonate absorption via single tracer method (PROCEDURE), Calcijex (DRUG).
Who is sponsoring clinical trial NCT00073710?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00073710's enrollment target sits among peer trials
30 1552nd of 2000 higher than 367 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia